{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:30:26Z","timestamp":1792553426236,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"vor","delay-in-days":50,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.neuropharm.2023.109426","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T18:21:33Z","timestamp":1674325293000},"page":"109426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Psychedelics: Science sabotaged by Social Media"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-2373","authenticated-orcid":false,"given":"Edward M.","family":"Sellers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myroslava K.","family":"Romach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2023.109426_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12954-019-0308-4","article-title":"Psychedelic micro-dosing benefits and challenges: an empirical codebook","volume":"16","author":"Anderson","year":"2019","journal-title":"Harm Reduct. J."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109426_bib2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/add.14939","article-title":"Marijuana use trends among college students in states with and without legalization of recreational use: initial and longer-term changes from 2008 to 2018","volume":"115","author":"Bae","year":"2020","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109426_bib3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109426_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00429082","article-title":"A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats","volume":"33","author":"Cameron","year":"1973","journal-title":"Psychopharmacologia"},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109426_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2215-0366(18)30133-0","article-title":"Antidepressants might work for people with major depression: where do we go from here?","volume":"5","author":"Cipriani","year":"2018","journal-title":"Lancet Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109426_bib6","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020705118","article-title":"Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission","volume":"118","author":"De Gregorio","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109426_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13143","article-title":"Repeated low doses of LSD in healthy adults: a placebo-controlled, dose-response study","volume":"27","author":"de Wit","year":"2022","journal-title":"Addiction Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109426_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/02791072.2019.1593561","article-title":"Might micro-dosing psychedelics Be safe and beneficial? An initial exploration","volume":"51","author":"Fadiman","year":"2019","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2023.109426_bib9","article-title":"Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity","author":"Glazer","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.neuropharm.2023.109426_bib10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2023.109426_bib11","author":"Grinspoon"},{"key":"10.1016\/j.neuropharm.2023.109426_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.640241","article-title":"Low doses of psilocybin and ketamine enhance motivation and attention in poor performing rats: evidence for an antidepressant property","volume":"12","author":"Higgins","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109426_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/FBP.0000000000000394","article-title":"Psilocin and ketamine micro-dosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats","volume":"29","author":"Horsley","year":"2018","journal-title":"Behav. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2023.109426_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ijnp\/pyz029","article-title":"Motives and side-effects of micro-dosing with psychedelics among users","volume":"22","author":"Hutten","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109426_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1037\/adb0000385","article-title":"Oregon recreational marijuana legalization: changes in undergraduates' marijuana use rates from 2008 to 2016. Psychology of addictive behaviors","volume":"32","author":"Kerr","year":"2018","journal-title":"journal of the Society of Psychologists in Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109426_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/00952990.2019.1599381","article-title":"Perceived prevalence of peer marijuana use: changes among college students before and after Oregon recreational marijuana legalization","volume":"45","author":"Koval","year":"2019","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.neuropharm.2023.109426_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320950567","article-title":"The therapeutic potential of micro-dosing psychedelics in depression","volume":"10","author":"Kuypers","year":"2020","journal-title":"Therapeutic advances in psychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109426_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/02791072.2019.1683260","article-title":"Psychedelic micro-dosing: a subreddit analysis","volume":"52","author":"Lea","year":"2020","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2023.109426_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.11.008","article-title":"Micro-dosing psychedelics: motivations, subjective effects and harm reduction","volume":"75","author":"Lea","year":"2020","journal-title":"Int. J. Drug Pol."},{"issue":"29","key":"10.1016\/j.neuropharm.2023.109426_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo0038","article-title":"Knowledge overconfidence is associated with anti-consensus views on controversial scientific issues","volume":"8","author":"Light","year":"2022","journal-title":"Sci. Adv."},{"issue":"18","key":"10.1016\/j.neuropharm.2023.109426_bib21","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMe2210975","article-title":"Psilocybin in treatment-resistant depression","volume":"387","author":"Madras","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109426_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/02698811211050556","article-title":"Psilocybin micro-dosing does not affect emotion-related symptoms and processing: a preregistered field and lab-based study","volume":"36","author":"Marschall","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neuropharm.2023.109426_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","article-title":"The promises and perils of psychedelic pharmacology for psychiatry","volume":"21","author":"McClure-Begley","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109426_bib25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41386-020-0694-z","article-title":"Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse","volume":"45","author":"Meinhardt","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109426_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42521","article-title":"Unintentional pediatric cannabis exposures after legalization of recreational cannabis in Canada","volume":"5","author":"Myran","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109426_bib27","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMc2207661","article-title":"Edible cannabis legalization and unintentional poisonings in children","volume":"387","author":"Myran","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109426_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211023","article-title":"A systematic study of micro-dosing psychedelics","volume":"14","author":"Polito","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109426_bib29","article-title":"Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-micro-dosing controls","volume":"12","author":"Rootman","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109426_bib30","author":"Sanchez"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109426_bib31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/cpt.697","article-title":"Psilocybin: good trip or bad trip","volume":"102","author":"Sellers","year":"2017","journal-title":"Clin. Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109426_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/cpt.776","article-title":"Psychedelic drugs as therapeutics: No illusions about the challenges","volume":"103","author":"Sellers","year":"2017","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.neuropharm.2023.109426_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuropharm.2017.11.029","article-title":"Studies with psychedelic drugs in human volunteers","volume":"142","author":"Sellers","year":"2018","journal-title":"Neuropharmacology"},{"issue":"14","key":"10.1016\/j.neuropharm.2023.109426_bib34","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.3390\/jcm10143109","article-title":"A new characterization of mental health disorders using digital behavioral data: evidence from major depressive disorder","volume":"10","author":"Taliaz","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109426_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41398-021-01488-3","article-title":"Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data","volume":"11","author":"Taliaz","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.neuropharm.2023.109426_bib37","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamapsychiatry.2022.2546","article-title":"Preparing for the bursting of the psychedelic hype bubble","volume":"79","author":"Yaden","year":"2022","journal-title":"JAMA Psychiatr."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:22:07Z","timestamp":1758439327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"alternative-id":["S0028390823000163"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109426","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychedelics: Science sabotaged by Social Media","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109426"}}